Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Like I was, I for like 24 hours I was very um. kind of sickish; the shot when she put the needle in it, it, it hurt a lot/I had a lot of pain; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Like I was, I for like 24 hours I was very um. kind of sickish) and VACCINATION SITE PAIN (the shot when she put the needle in it, it, it hurt a lot/I had a lot of pain) in an elderly female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Immunocompromised and Lung disorder NOS. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced MALAISE (Like I was, I for like 24 hours I was very um. kind of sickish) and VACCINATION SITE PAIN (the shot when she put the needle in it, it, it hurt a lot/I had a lot of pain). At the time of the report, MALAISE (Like I was, I for like 24 hours I was very um. kind of sickish) and VACCINATION SITE PAIN (the shot when she put the needle in it, it, it hurt a lot/I had a lot of pain) outcome was unknown. No concomitant medications were reported. It was reported that the patient had medical history of rare disease. Administration date was reported as a couple of months ago. It was unknown if the patient experienced any additional symptoms/events. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 20-Feb-2025: Non-significant follow-up received, and reference number added On 20-Feb-2025: Upon internal review on 12-Mar-2025, significant correction was performed to update suspect product coding from COVID-19 vaccine to Spikevax NOS.
Immunocompromised; Lung disorder NOS